285 related articles for article (PubMed ID: 26993102)
21. In vitro effect of relaxin in the rat corpus cavernosum under hyperglycemic and normoglycemic conditions.
Acar-Sahan S; Guner O; Ates M; Kaya-Temiz T; Durmus N
Int J Impot Res; 2024 Feb; 36(1):72-77. PubMed ID: 36509910
[TBL] [Abstract][Full Text] [Related]
22. Serelaxin: A Novel Therapeutic for Vascular Diseases.
Leo CH; Jelinic M; Ng HH; Tare M; Parry LJ
Trends Pharmacol Sci; 2016 Jun; 37(6):498-507. PubMed ID: 27130518
[TBL] [Abstract][Full Text] [Related]
23. Low micromolar concentrations of copper augment the impairment of endothelium-dependent relaxation of aortae from diabetic rabbits.
Shukla N; Thompson CS; Angelini GD; Mikhailidis DP; Jeremy JY
Metabolism; 2004 Oct; 53(10):1315-21. PubMed ID: 15375788
[TBL] [Abstract][Full Text] [Related]
24. Treatment with sodium nitroprusside improves the endothelial function in aortic rings with endothelial dysfunction.
Buzinari TC; Oishi JC; De Moraes TF; Vatanabe IP; Selistre-de-Araújo HS; Pestana CR; Rodrigues GJ
Eur J Pharm Sci; 2017 Jul; 105():144-149. PubMed ID: 28456572
[TBL] [Abstract][Full Text] [Related]
25. Fenofibrate improves vascular endothelial function in diabetic mice.
Xin R; An D; Li Y; Fu J; Huang F; Zhu Q
Biomed Pharmacother; 2019 Apr; 112():108722. PubMed ID: 30970521
[TBL] [Abstract][Full Text] [Related]
26. Chronic inhibition of nitric-oxide synthase potentiates endothelium-dependent contractions in the rat aorta by augmenting the expression of cyclooxygenase-2.
Qu C; Leung SW; Vanhoutte PM; Man RY
J Pharmacol Exp Ther; 2010 Aug; 334(2):373-80. PubMed ID: 20444882
[TBL] [Abstract][Full Text] [Related]
27. Recent Progress in the Therapeutic Role of Serelaxin in Vascular Dysfunction.
Murtaza G; Siddiqui A; Hussain I
Curr Protein Pept Sci; 2018; 19(11):1079-1087. PubMed ID: 29984650
[TBL] [Abstract][Full Text] [Related]
28. Imbalanced synthesis of cyclooxygenase-derived thromboxane A2 and prostacyclin compromises vasomotor function of the thoracic aorta in Marfan syndrome.
Chung AW; Yang HH; van Breemen C
Br J Pharmacol; 2007 Oct; 152(3):305-12. PubMed ID: 17641673
[TBL] [Abstract][Full Text] [Related]
29. Type 1 diabetes and hypercholesterolaemia reveal the contribution of endothelium-derived hyperpolarizing factor to endothelium-dependent relaxation of the rat aorta.
Malakul W; Thirawarapan S; Suvitayavat W; Woodman OL
Clin Exp Pharmacol Physiol; 2008 Feb; 35(2):192-200. PubMed ID: 17941894
[TBL] [Abstract][Full Text] [Related]
30. A change in the redox environment and thromboxane A2 production precede endothelial dysfunction in mice.
Gendron ME; Thorin E
Am J Physiol Heart Circ Physiol; 2007 Oct; 293(4):H2508-15. PubMed ID: 17644574
[TBL] [Abstract][Full Text] [Related]
31. Increased superoxide production and altered nitric oxide-mediated relaxation in the aorta of young but not old male relaxin-deficient mice.
Ng HH; Jelinic M; Parry LJ; Leo CH
Am J Physiol Heart Circ Physiol; 2015 Jul; 309(2):H285-96. PubMed ID: 25957220
[TBL] [Abstract][Full Text] [Related]
32. Mutation of the circadian clock gene Per2 alters vascular endothelial function.
Viswambharan H; Carvas JM; Antic V; Marecic A; Jud C; Zaugg CE; Ming XF; Montani JP; Albrecht U; Yang Z
Circulation; 2007 Apr; 115(16):2188-95. PubMed ID: 17404161
[TBL] [Abstract][Full Text] [Related]
33. 15-Hydroxyeicosatetraenoic acid and diabetic endothelial dysfunction in rabbit aorta.
Tesfamariam B; Brown ML; Cohen RA
J Cardiovasc Pharmacol; 1995 May; 25(5):748-55. PubMed ID: 7630153
[TBL] [Abstract][Full Text] [Related]
34. Magnesium modulates endothelial dysfunction produced by elevated glucose incubation.
Félétou M; Rasetti C; Duhault J
J Cardiovasc Pharmacol; 1994 Sep; 24(3):470-8. PubMed ID: 7528304
[TBL] [Abstract][Full Text] [Related]
35. Luteolin reduces high glucose-mediated impairment of endothelium-dependent relaxation in rat aorta by reducing oxidative stress.
Qian LB; Wang HP; Chen Y; Chen FX; Ma YY; Bruce IC; Xia Q
Pharmacol Res; 2010 Apr; 61(4):281-7. PubMed ID: 19892019
[TBL] [Abstract][Full Text] [Related]
36. Endothelial dysfunction and compromised eNOS/Akt signaling in the thoracic aorta during the progression of Marfan syndrome.
Chung AW; Au Yeung K; Cortes SF; Sandor GG; Judge DP; Dietz HC; van Breemen C
Br J Pharmacol; 2007 Apr; 150(8):1075-83. PubMed ID: 17339838
[TBL] [Abstract][Full Text] [Related]
37. Cyclooxygenase-2 inhibition improves vascular endothelial dysfunction in a rat model of endotoxic shock: role of inducible nitric-oxide synthase and oxidative stress.
Virdis A; Colucci R; Fornai M; Blandizzi C; Duranti E; Pinto S; Bernardini N; Segnani C; Antonioli L; Taddei S; Salvetti A; Del Tacca M
J Pharmacol Exp Ther; 2005 Mar; 312(3):945-53. PubMed ID: 15547110
[TBL] [Abstract][Full Text] [Related]
38. Pregnancy-induced changes in endothelium-independent relaxation.
Bobadilla Lugo RA; Castillo Henkel E; Perez-Alvarez VM; Castillo Henkel C
Proc West Pharmacol Soc; 1998; 41():93-4. PubMed ID: 9836257
[No Abstract] [Full Text] [Related]
39. Crocetin improves endothelium-dependent relaxation of thoracic aorta in hypercholesterolemic rabbit by increasing eNOS activity.
Tang FT; Qian ZY; Liu PQ; Zheng SG; He SY; Bao LP; Huang HQ
Biochem Pharmacol; 2006 Aug; 72(5):558-65. PubMed ID: 16876766
[TBL] [Abstract][Full Text] [Related]
40. Endothelial dysfunction in rat adjuvant-induced arthritis: up-regulation of the vascular arginase pathway.
Prati C; Berthelot A; Wendling D; Demougeot C
Arthritis Rheum; 2011 Aug; 63(8):2309-17. PubMed ID: 21484767
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
